1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. QUOIN PHARMACEUTICALS LTD - ADR

Quoin Pharmaceuticals Ltd - ADR

XNAS: QNRX

Download real time

0.29 -0.01 (-3.33%)

81.53% Fall from 52W High

330.9K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
12W
1O
0T
2.4

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
0.4

Price to Book

Below industry Median
0.3

Beta 1Year

Very Low volatility


Insider Trading disclosures for Quoin Pharmaceuticals Ltd - ADR

The latest disclosure was made by Culverwell James Anthony in Quoin Pharmaceuticals Ltd - ADR where a trade of 100,000 Series G Warrants (right to buy) done was reported to US exchanges on Dec. 23, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Culverwell James Anthony Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 100,000 100,000 - - Series G Warrants (right to buy)
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 555,556 602,648 - 0.4 250,000 Ordinary Shares
Anthony James Culverwell Director Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 100,000 100,317 - 0.5 45,000 Ordinary Shares
Anthony James Culverwell Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 100,000 100,000 - - Series F Warrants (right to buy)
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 122,221 122,221 - - Series G Warrants (right to buy)
Myers Michael Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 555,556 602,808 - 0.4 250,000 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series G Warrants (right to buy)
Dunn Gordon Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 122,221 151,077 - 0.4 54,999 Ordinary Shares
Myers Michael Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series G Warrants (right to buy)
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series F Warrants (right to buy)
Carter Denise Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series F Warrants (right to buy)
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 122,221 122,221 - - Series F Warrants (right to buy)
Gordon Dunn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 338,994 338,994 - - Share Option (Right to Buy)
Natalie Leong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Denise Carter Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 536,609 536,609 - - Share Option (Right to Buy)
Michael Myers Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 536,603 536,603 - - Share Option (Right to Buy)
Anthony James Culverwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Joseph P. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Dennis H. Langer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.78 per share. 09 Sep 2024 4,000 4,856 - 0.8 3,120 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 09 Sep 2024 856 856 - 0.8 685 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 09 Sep 2024 10,000 28,856 - 0.7 7,100 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.91 per share. 09 Sep 2024 10,000 18,856 - 0.9 9,100 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 09 Sep 2024 4,000 8,856 - 0.8 3,200 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.75 per share. 03 Sep 2024 8,825 24,104 - 0.7 6,602 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.66 per share. 03 Sep 2024 4,100 15,279 - 0.7 2,686 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.63 per share. 03 Sep 2024 1,822 11,179 - 0.6 1,139 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 03 Sep 2024 22,988 47,092 - 0.8 18,310 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.75 per share. 03 Sep 2024 8,200 23,680 - 0.7 6,134 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.66 per share. 03 Sep 2024 5,322 15,480 - 0.7 3,490 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.62 per share. 03 Sep 2024 800 10,158 - 0.6 495 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 03 Sep 2024 23,572 47,252 - 0.8 18,796 Ordinary Shares
Dennis H. Langer Director Sale of securities on an exchange or to another person at price $ 0.73 per share. 07 Jun 2024 297 53 - 0.7 217 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters